Announcements Trials

Browse Landscape

Phase

Phase 2 9 Phase 3 2 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 2 Tumor-Agnostic 1 Thoracic 1 Gastrointestinal 1

Conditions

Interventions

Carboplatin 16 Pemetrexed 15 Cisplatin 15 Erlotinib Hydrochloride 13 icotinib 8 Propofol 7 Gefitinib 7 Gemcitabine 6 Docetaxel 6 endostar protein 5 Saline Solution 5 Paclitaxel 5 Nivolumab 5 Endostatins 5 tislelizumab 4 lorlatinib 4 anlotinib 4 Vinorelbine 4 Sevoflurane 4 Drug Therapy 4 Afatinib 4 pembrolizumab 3 durvalumab 3 atezolizumab 3 Zoledronic Acid 3 Radiotherapy 3 Dexamethasone 3 Acetaminophen 3 trilaciclib 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Thalidomide × Thoracic × Clear all

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡